Sarvapriya Healthcare Solutions Private Limited entered into a binding agreement to acquire 42.36% stake in Dalmia Bharat Refractories Limited from Dalmia Bharat Sugar and Industries Limited (BSE:500097) for INR 8 billion on March 25, 2023. About INR 1.6 billion will be paid on Consummation of transaction, INR 3.2 billion will be paid by way of NCDs redeemable on or before December 31, 2023, and INR 3.2 billion will be paid by way of NCDs redeemable on or before September, 30, 2024. Dalmia board has approved the transaction. Transaction is expected to close on or before April 25, 2023. Zia Mody, Ashwath Rau and Kashish Bhatia of AZB & Partners acted as legal advisors to Sarvapriya Healthcare Solutions Private Limited.

Sarvapriya Healthcare Solutions Private Limited completed the acquisition of 42.36% stake in Dalmia Bharat Refractories Limited from Dalmia Bharat Sugar and Industries Limited (BSE:500097) for INR 8 billion on April 25, 2023.